Polarization of human hematopoietic progenitors during contact with multipotent mesenchymal stromal cells:: Effects on proliferation and clonogenicity

被引:60
作者
Freund, Daniel
Bauer, Nicola
Boxberger, Sabine
Feldmann, Silvia
Streller, Uwe
Ehninger, Gerhard
Werner, Carsten
Bornhaeuser, Martin
Oswald, Joachim
Corbeil, Denis
机构
[1] Tech Univ Dresden, BIOTEC, Tissue Engn Labs, D-01307 Dresden, Germany
[2] Univ Hosp Carl Gustav Carus, Med Clin, D-01307 Dresden, Germany
[3] Univ Hosp Carl Gustav Carus, Policlin 1, D-01307 Dresden, Germany
[4] Max Bergmann Ctr Biomat Dresden, D-01069 Dresden, Germany
关键词
D O I
10.1089/scd.2006.15.815
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Establishment of a defined cell culture system that facilitates ex vivo expansion of isolated hematopoietic stem and progenitor cells (HSPCs) is a crucial issue in hematology and stem cell transplantation. Here we have evaluated the capacity of primary human multipotent mesenchymal stromal cells (MSCs) to support the ex vivo expansion of peripheral CD34(+)-enriched HSPCs. We observed that HSPCs co-cultured on MSCs showed a substantially higher total expansion rate compared to those growing without. Moreover, in addition to the expansion of CD34(+)CD133(+) and CD34(+)CD133(+) cells, a third population of CD133(+)CD34(+) stem cells became detectable after expansion. Direct contact between HSPCs and the feeder layer appears beneficial for the expansion of HSPCs harboring CD133(+) phenotype, i.e., CD34(+)CD133(+) and CD133(+)CD34(+), in contrast to CD34(+)CD133(+) cells. Interestingly, electron microscopy and immunofluorescence analyses revealed that adherent HSPCs display various morphologies; they are either round with, in some cases, the appearance of a microvillar pole or exhibit several distinct types of plasma membrane protrusions such as lamellipodium and magnupodium. CD133 is selectively concentrated therein, whereas CD34 is randomly distributed over the entire surface of HSPCs. Together, this co-culture offers a unique experimental system to further characterize the biology and role of markers of rare stem cell populations.
引用
收藏
页码:815 / 829
页数:15
相关论文
共 46 条
[1]   Stroma-contact prevents loss of hematopoietic stem cell quality during ex vivo expansion of CD34+ mobilized peripheral blood stem cells [J].
Breems, DA ;
Blokland, EAW ;
Siebel, KE ;
Mayen, AEM ;
Engels, LJA ;
Ploemacher, RE .
BLOOD, 1998, 91 (01) :111-117
[2]  
Corbeil D, 1999, J CELL SCI, V112, P1023
[3]   Prominin:: A story of cholesterol, plasma membrane protrusions and human pathology [J].
Corbeil, D ;
Röper, K ;
Fargeas, CA ;
Joester, A ;
Huttner, WB .
TRAFFIC, 2001, 2 (02) :82-91
[4]   The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions [J].
Corbeil, D ;
Röper, K ;
Hellwig, A ;
Tavian, M ;
Miraglia, S ;
Watt, SM ;
Simmons, PJ ;
Peault, B ;
Buck, DW ;
Huttner, WB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (08) :5512-5520
[5]   Dissociation between stem cell phenotype and NOD/SCID repopulating activity in human peripheral blood CD34+ cells after ex vivo expansion [J].
Danet, GH ;
Lee, HW ;
Luongo, JL ;
Simon, MC ;
Bonnet, DA .
EXPERIMENTAL HEMATOLOGY, 2001, 29 (12) :1465-1473
[6]   CD34+AC133+ cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors [J].
de Wynter, EA ;
Buck, D ;
Hart, C ;
Heywood, R ;
Coutinho, LH ;
Clayton, A ;
Rafferty, JA ;
Burt, D ;
Guenechea, G ;
Bueren, JA ;
Gagen, D ;
Fairbairn, LJ ;
Lord, BI ;
Testa, NG .
STEM CELLS, 1998, 16 (06) :387-396
[7]  
DEXTER TM, 1990, CIBA F SYMP, V148, P76
[8]  
Dorrell C, 2000, BLOOD, V95, P102
[9]   Prominin-1 (CD133): from progenitor cells to human diseases [J].
Fargeas, Christine A. ;
Fonseca, Ana-Violeta ;
Huttner, Wieland B. ;
Corbeil, Denis .
FUTURE LIPIDOLOGY, 2006, 1 (02) :213-225
[10]   Two new pseudopod morphologies displayed by the human hematopoietic KG1a progenitor cell line and by primary human CD34+ cells [J].
Francis, K ;
Ramakrishna, R ;
Holloway, W ;
Palsson, BO .
BLOOD, 1998, 92 (10) :3616-3623